903 related articles for article (PubMed ID: 32567187)
21. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
22. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
[TBL] [Abstract][Full Text] [Related]
25. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
Bian Z; Fan R; Xie L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
[TBL] [Abstract][Full Text] [Related]
26. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
Pang S; Zhao S; Dongye Y; Fan Y; Liu J
Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
[TBL] [Abstract][Full Text] [Related]
29. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
Bao W; Han Q; Guan X; Wang Z; Gu M
Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
[TBL] [Abstract][Full Text] [Related]
30. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
Liu JW; Supandi F; Dhillon SK
Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
[TBL] [Abstract][Full Text] [Related]
31. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N
Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511
[TBL] [Abstract][Full Text] [Related]
32. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Hong Y; Lin M; Ou D; Huang Z; Shen P
BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
[TBL] [Abstract][Full Text] [Related]
33. Influence of gene expression on survival of clear cell renal cell carcinoma.
Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
[TBL] [Abstract][Full Text] [Related]
34. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
[TBL] [Abstract][Full Text] [Related]
35. Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
Yoon JY; Gedye C; Paterson J; Ailles L
BMC Cancer; 2020 Apr; 20(1):272. PubMed ID: 32245446
[TBL] [Abstract][Full Text] [Related]
36. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
39. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
40.
Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
